Patent_application_number,Applicant_name,Year_of_application,Patent_system
US7314713B1,MYRIAD GENETICS,2008,USPTO
US7319011B2,DUKE UNIVERSITY,2008,USPTO
US7319142B1,BAYER,2008,USPTO
US7326417B2,BOEHRIGER INGELHEIM,2008,USPTO
US7326537B2,GSK PLC,2008,USPTO
US7326552B1,TAKEDA CHEMICAL INDUSTRIES LTD,2008,USPTO
US7326771B2,"MONTEREY BAY AQUARIUM RESEARCH INSTITUTE; MOSS LANDING, CA; US;",2008,USPTO
US7329511B2,UNIVERSITY OF CALIFORNIA,2008,USPTO
US7332568B2,BRISTOL-MYERS SQUIBB COMPANY,2008,USPTO
US7332575B2,JOHNS HOPKINS UNIVERSITY,2008,USPTO
US7335469B2,ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,2008,USPTO
US7341832B2,STANFORD UNIVERSITY,2008,USPTO
US7341850B2,"WYETH; MADISON, NJ; US;",2008,USPTO
US7341995B2,MERCK,2008,USPTO
US7342102B2,ROCHE DIAGNOSTICS,2008,USPTO
US7351566B2,TAKEDA CHEMICAL INDUSTRIES LTD,2008,USPTO
US7354709B2,NATIONAL TAIWAN UNIVERSITY,2008,USPTO
US7354745B2,UNIVERSITY OF WISCONSIN-MADISON,2008,USPTO
US7358042B2,"AURELIUM BIOPHARMA, INC.; MONTREAL, QUEBEC; CA;",2008,USPTO
US7358057B2,ROCHE DIAGNOSTICS,2008,USPTO
US7361478B2,ABBVIE INC,2008,USPTO
US7364864B2,OXFORD UNIVERSITY,2008,USPTO
US7364887B2,SANOFI,2008,USPTO
US7365185B2,BAYER,2008,USPTO
US7368248B2,CENIX BIOSCIENCE GMBH; DRESDEN; DE;,2008,USPTO
US7368531B2,GSK PLC,2008,USPTO
US7371723B2,UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INC. (US),2008,USPTO
US7371850B1,MYRIAD GENETICS,2008,USPTO
US7374760B2,THE UNIVERSITY OF CHICAGO,2008,USPTO
US7374913B2,EIKEN KAGAKU KABUSHIKI KAISHA; TOKYO; JP;,2008,USPTO
US7381541B2,BASF,2008,USPTO
US7381549B2,BASF,2008,USPTO
US7384739B2,TOYOBO CO LTD,2008,USPTO
US7384775B2,"WYETH; MADISON, NJ; US;",2008,USPTO
US7390645B2,RICE UNIVERSITY,2008,USPTO
US7393663B2,SERONO GENETICS INSTITUTE S.A.; EVRY; FR;,2008,USPTO
US7393666B2,"BURNHAM INSTITUTE FOR MEDICAL RESEARCH; LA JOLLA, CA; US;",2008,USPTO
US7405050B2,PRINCETON UNIVERSITY,2008,USPTO
US7407784B2,MAX PLANCK SOCIETY,2008,USPTO
US7408028B2,SINAPORE GENERAL HOSPITAL PTE LTD.; SINGAPORE; SG;,2008,USPTO
US7408052B2,BAYER,2008,USPTO
US7411052B2,THERMO FISHER SCIENTIFIC,2008,USPTO
US7411055B2,AMGEN,2008,USPTO
US7414019B2,AUCKLAND UNISERVICES LIMITED; AUCKLAND; NZ;,2008,USPTO
US7414119B2,BASF,2008,USPTO
US7415358B2,OCIMUM BIOSOLUTIONS,2008,USPTO
US7416849B2,THERMO FISHER SCIENTIFIC,2008,USPTO
US7416851B2,INSTITUT PASTEUR,2008,USPTO
US7419779B2,RIGEL PHARMACEUTICALS,2008,USPTO
US7420044B1,"ABT HOLDING COMPANY; CLEVELAND, OH; US;",2008,USPTO
US7422747B2,LOMA LINDA UNIVERSITY,2008,USPTO
US7422849B1,LUDWIG INSTITUTE FOR CANCER RESEARCH,2008,USPTO
US7422888B2,TAKARA HOLDINGS,2008,USPTO
US7424370B2,CSIR,2008,USPTO
US7425445B2,DUKE UNIVERSITY,2008,USPTO
US7429449B2,SANOFI,2008,USPTO
US7432049B2,"CHONDROGENE LIMITED; TORONTO, ONTARIO; CA;",2008,USPTO
US7432350B2,"CROPSOLUTION, INC.; MORRISVILLE, NC; US;",2008,USPTO
US7439327B2,THERMO FISHER SCIENTIFIC,2008,USPTO
US7439328B2,CORNELL UNIVERSITY,2008,USPTO
US7442501B2,MIT,2008,USPTO
US7446176B2,GSK PLC,2008,USPTO
US7447594B2,OCIMUM BIOSOLUTIONS,2008,USPTO
US7452678B2,BRISTOL-MYERS SQUIBB COMPANY,2008,USPTO
US7462465B2,AMGEN,2008,USPTO
US7462706B2,UNIVERSITY OF CALIFORNIA,2008,USPTO
US7469185B2,OCIMUM BIOSOLUTIONS,2008,USPTO